Seven point mutations were introduced into region I of the herpes simplex virus type 1 DNA polymerase, which is most highly conserved among DNA polymerases and has no drug sensitivity markers mapped to it. The functional consequences of these mutations were studied in an in vitro transcription-translation system in which T7 transcripts of cloned polymerase genes were used to generate enzymatically active polypeptides in reticulocyte lysate. Analysis of labeled polypeptides on sodium dodecyl sulfate-polyacrylamide gel electrophoresis failed to show any alterations of stability caused by these mutations. The mutations G885R, D886N, T887K, D888A, and G896V lacked polymerase activity and failed to be stimulated by cotranslation of the herpes simplex virus 65-kilodalton DNA-binding protein, whereas R881G and S889A retained both polymerase activity and the capacity to be stimulated by the 65-kilodalton DNA-binding protein.
Herpes simplex virus (HSV) type 1 (HSV-1) DNA polymerase serves as a useful model for the study of viral DNA replication and its inhibition by antiviral drugs. It is now clear that HSV polymerase is a member of a large family of DNA polymerases which includes those from bacteriophages, other animal viruses, and replicative polymerases of lower eucaryotes (Saccharomyces cerevisiae) and higher eucaryotes (human) (1-3, 8, 13, 15, 19, 20, 26, 28, 31, 32) . The basis for grouping these proteins in one family is that they share regions of striking sequence similarity and that these regions occur in the same order in all members. The sequence relatedness of these proteins suggests that they may share basic molecular mechanisms and that functional sites may reside within the conserved regions and can help to direct studies aimed at understanding the roles of particular sites in polymerase function.
Little is known, at present, about functional domains within HSV polymerase, in contrast to several of the procaryotic DNA polymerases. The structure of Escherichia coli polymerase I has been solved (22) , and much is understood about how various domains within that protein contribute to enzymatic activity (9, 14, 22) . Although several enzymatic activities are associated with HSV polymerase (deoxynucleoside triphosphate binding, DNA chain elongation, a 3' exonuclease, and pyrophosphate binding) (6, 16, 25) , the localization of these activities within the 140-kilodalton (kDa) protein molecule is not apparent. Recent characterization of altered drug sensitivity markers in HSV polymerase has revealed several mutations occuring in three of the six most highly conserved regions of the polymerase gene, pol (12, 18, 20, 29) . Because of clustering of mutations in regions II and III it has been hypothesized that amino acids in these regions interact directly with deoxynucleoside triphosphates and their analogs (12, 20) . Region I (Fig. 1) , the most highly conserved region, is of particular interest, since no drug resistance mutations have been found in it. Also, it has been shown that a 78-residue deletion spanning region I abolishes enzyme activity and is lethal to the function of the gene in a biological complementation assay * Corresponding author. (7) . Because of the significant evolutionary conservation of region I and the fact that no function has been assigned to it, the construction of mutants with alterations at the sites of conserved residues should be helpful in learning the role of region I in polymerase function. Also, because DNA polymerase enzymatic activity can be detected by in vitro transcription-translation of cloned HSV pol genes, this allows the study of the effects of mutations introduced into the pol gene on enzymatic activity. This system allows for the screening of mutants with intact enzymatic activity which may lack biological activity due to intracellular instability or failure to interact properly with other elements of the viral replicative machinery. Seven point mutations were introduced into pol region I by the strategy shown in Fig. 2 by 5' AAAGATGGCGTCCGTGT; 907/G896V/G3090T, 5' CCGTGAGGACGCGGCAC. The mutagenic oligonucleotides were of negative polarity with respect to the translation frame of the pol gene, as was the 16-mer used as a primer to conveniently sequence the region I DNA, 5' CAGCGCGCGCGAGATG (position 3139). The numbering system used was that of Quinn and McGeoch (26) . Mutagenesis was carried out by the method of Nakamaye and Eckstein (21) with an Amersham oligonucleotide-directed in vitro mutagenesis system. The introduction of mutations into mpPOL3 was confirmed by dideoxy sequencing and a 746-base-pair MstII-NotI subfragment of mpPOL3 was inserted into a complementary 7.9-kilobase MstIl-NotI fragment of the T7 expression vector pGEM2-702. The resulting plasmids were named pD901 through pD907. Verification of the construction was carried out by direct dideoxy sequencing of the resulting plasmids, which were used as templates for T7 RNA polymerase transcription. using oligonucleotide-directed mutagenesis (21) . (Plasmid numbers and mutations were as follows: pD901, R881G; pD902, G885R; pD903, D886N; pD904, T887K; pD905, D888A; pD906, S889A; pD907, G896V.) The mutations were introduced into a previously described M13 vector, mp8, containing a 3.5-kilobase PstI-SacI fragment of pol (mpPOL3) (7), which was used for verification of the mutagenesis by DNA sequencing (27) . After mutagenesis, the 746-base-pair MstII-NotI subfragments containing wild-type and mutant pol sequences were inserted into a complementary 7.7-kilobase MstII-NotI fragment of pGEM2-702, and the constructions were verified by direct dideoxy sequencing of the plasmids (4).
The resulting set of T7 expression vectors containing pol gene mutations were used as templates for in vitro T7 RNA polymerase transcripts capable of programming in vitro translation in rabbit reticulocyte lysates. In vitro-translated pol has been shown to possess DNA polymerase enzymatic activity when assayed by standard methods on an activated calf thymus DNA template (7) . The in vitro pol RNA was translated in rabbit reticulocyte lysates in the presence of [35S]methionine for analysis by sodium dodecyl sulfatepolyacrylamide gel electrophoresis fluorography or in the presence of nonradioactive amino acids for enzyme assays. The major product of the pol gene migrates as a 140-kDa polypeptide (7) . Included in these assays was the mutant T7-7.1, which specifies an HSV-1 DNA polymerase with a 67-residue amino-terminal deletion expressed as a fusion with the six amino-terminal residues of phage T7 gene 10. As previously reported, this 135-kDa polypeptide possesses up to fivefold the polymerase activity of the wild-type polypeptide when these activities were assayed by in vitro transcription-translation (7). The mechanism for this enhancement is not understood at present. Wild-type and mutant polypeptides are displayed in Fig. 3 ; no gross differences between wild-type and mutant polypeptides can be detected. Because incorporation of [35S]methionine into the in vitro translation product is linear over the 90-min labeling period and no significant differences in proteolytic degradation could be detected, the results suggest that the pol region I point mutants are equally well translated as the wild-type pol and that none is preferentially degraded in reticulocyte lysate. When assayed for polymerase activity, mutants 901 and 906 were found to possess significant DNA polymerase activity (Fig. 4) (11, 23) . Recently, it has been shown that cotranslation of pol and the 65-kDa DBP in reticulocyte lysates results in a specific stimulation of pol activity (10) . The exact mechanism of this stimulation is unknown, but it is hypothesized that the 65-kDa DBP is a DNA polymerase accessory protein (10, 11, 23) . The stimulated by the 65-kDa DBP (Table 1 ). The degree of stimulation noted in previous studies varied between 2-and 10-fold (10) . None of the active mutants, including the amino-terminal deletion T7-7.1 (67 amino-terminal residues deleted), failed to be stimulated by the 65-kDa DBP. Because none of the inactive mutants was stimulated, it is likely . DNA polymerase activity of in vitro translation products. RNA (4 ,ug) obtained from linearized templates by in vitro T7 transcription was translated in 25 ,ul of rabbit reticulocyte lysate for 90 min at 30°C. The 25-,ul translation mixtures were assayed for DNA polymerase activity by measurement of acid-precipitable radioactivity incorporated at 37°C for 20 min by using [(s-32P]dCTP as described previously (7) . DBP, 65-kDa DBP obtained from the plasmid LBN19a (10); 701, a deletion mutant of HSV-1 pol lacking residues 881 through 959 (7); T7-7.1, a deletion mutant of HSV-1 pol lacking the amino-terminal 67 residues (7). One unit of polymerase activity is defined as 1 fmol of [cx-32P]dCMP incorporated into an activated calf thymus DNA template at 37°C per h per ml of rabbit reticulocyte lysate. Fig. 4 .
that none of them possessed activity that was just barely subthreshold for the assay, because stimulation would have augmented it to detectable levels. However, the possibility cannot be ruled out that the inactive mutations specifically affected the interaction between the DNA polymerase and the 65-kDa DBP. The simplest interpretation of these results, however, is that mutations in region I that do not abolish polymerase activity in vitro have no obvious effect on the interaction between the polymerase and the 65-kDa DBP. In summary, a set of mutants in HSV pol region I has been constructed with alterations in seven conserved residues (Fig. 5) . When evaluated for their effects on enzymatic function in an in vitro transcription-translation system, five of the seven mutants were found to lack any enzymatic activity. Furthermore, these five mutants failed to show any activity when cotranslated with the 65-kDa DBP, which has been shown to be capable of between 2-and 10-fold stimulation of polymerase activity in this system (10) . None of the mutants appeared to be significantly less stable in rabbit reticulocyte lysate than the wild-type polypeptide. Interestingly, two substitutions retained approximately wild-type levels of activity. The 901 mutant (R881G), with about one-third of the wild-type activity, nevertheless retained the ability to be stimulated by the 65-kDa DBP. The R881 residue happens to be present in six of the family members shown, with another basic residue, lysine, present at that position in two other members (Fig. 1) 
